Bibliographic information
Recommendation
For symptomatic patients with COVID-19 and risk factors for progression to severe disease who are not hospitalized, the WHO suggests the use of pulse oximetry monitoring at home as part of a package of care, including patient and provider education and appropriate follow-up.
Recommended in favor
Conditional
Certainty of evidence
Very low
Notes and Remarks
Practical info The GDG made a conditional recommendation for the use of home pulse oximetry monitoring. This recommendation is predicated on the availability and accessibility of high-quality and reliable pulse oximeters for home use; the integration of home pulse oximetry into a health system, from a training and human resources perspective; and targeting the intervention to patients who would likely get the most benefit, namely those at high-risk and those who are symptomatic. Also, no recommendation was made on the frequency or duration of pulse oximetry monitoring. Note: training on appropriate IPC (cleaning and disinfection) should be included.
Important considerations Home oximetry monitoring is not accessible to many patients, due to lack of available equipment, lack of relevant personnel to monitor it, lack of ability to interpret the results at home, or lack of knowledge about implementation. Home pulse oximetry may be useful in certain settings, including low resource settings, particularly when hospitals are strained and where it may be necessary to effectively monitor patients in a home-based setting. However home oximetry monitoring will only be of value if the users are adequately informed on how to interpret the readings and have ready access to providers who can advise on the response to readings. Considerations for education and training of patients and providers, as well as adequate staffing, to implement care pathways with available access to acute care will need to be integrated.
Also Featured In
This recommendation also appears in the following guidelines:
COVID-19 clinical management: living guidance, 25 January 2021.
Living guidance for clinical management of COVID-19: living guidance, 23 November 2021.
Clinical management of COVID-19: living guideline, 23 June 2022.
Clinical management of COVID-19: living guideline, 15 September 2022.
Clinical management of COVID-19: living guideline, 13 January 2023.
Clinical management of COVID-19: living guideline, 18 August 2023